Skip to main content
Erschienen in: Supportive Care in Cancer 5/2016

01.05.2016 | Original Article

Home management of acute medical complications in cancer patients: a prospective pilot study

verfasst von: C. Font, F. Fernández-Avilés, C. Calderon, T. García-Fernández, N. Arab, E. Pineda, E. Buxó, P. Ayora, M. Carreño, V. Pereira, M. Viladot, C. Moreno, C. Gallego, A. Hernando, N. Creus, C. Barrera, R. Alcaraz, J. Sanchez, A. Prat, A. Tuca

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The development of reliable alternatives to conventional hospitalization in patients with cancer would have great clinical and economical value. The aim of the present study was to assess the feasibility of a home-based nursing intervention model as a safe alternative for the management of acute medical complications in cancer patients who would otherwise require conventional hospitalization.

Patients and methods

From October 2013 to October 2014, we prospectively evaluated the outcomes of consecutive acute medical episodes treated at home under the home-based intervention program named the Bridge Project (BP). Episodes were classified as “avoided hospitalization in outpatients” (AHO) vs. “reduced hospitalization in inpatients” (RHI). The primary end-point was to assess the rate and causes of BP intervention failure (unplanned hospital readmission or death).

Results

Two hundred and forty-six consecutive episodes (52 % AHO and 48 % RHI) involving 203 patients (55 % male; mean age 63 years) were enrolled. The main conditions managed at home were non-neutropenic infections (40 %), febrile neutropenia (20 %), and cancer-related complications (28 %). The median duration of the BP intervention was 5 days (range 1–16 days). No deaths were reported at home. Unplanned hospital readmissions occurred in 9 % of episodes (14 % in AHO vs. 4 % in RHI; p = 0.001). Five of the 22 readmitted patients (22.7 % of the BP failures; 2.5 % of the whole series) died during hospitalization. The BP intervention burden was 1353 days, representing a potential saving of 14 % of days of hospitalization during the study period.

Conclusions

The BP is a safe intervention which can potentially avoid or reduce the length of hospitalization in selected cancer patients with acute medical complications. Our findings support further development of innovative home-based clinical approaches to promote potentially avoidable hospitalization in this setting.
Literatur
2.
Zurück zum Zitat Decoster L, Van Puyelde K, Mohile S et al (2015) Screening tools for multidimensional healths problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 26:288–300CrossRefPubMed Decoster L, Van Puyelde K, Mohile S et al (2015) Screening tools for multidimensional healths problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 26:288–300CrossRefPubMed
3.
4.
Zurück zum Zitat Sanchez MJ, Payer T, De Angelis R et al (2010) Cancer incidence and mortality in Spain: estimates and projections for the period 1981–2012. Ann Oncol 21(Suppl 3):iii30–36PubMed Sanchez MJ, Payer T, De Angelis R et al (2010) Cancer incidence and mortality in Spain: estimates and projections for the period 1981–2012. Ann Oncol 21(Suppl 3):iii30–36PubMed
5.
Zurück zum Zitat De Azambuia E, Ameye L, Paesmans M, Zielinsky CC, Piccart-Gebhart M, Preusser M (2014) The landscape of medical oncology in Europe by 2020. Ann Oncol 25:525–528CrossRef De Azambuia E, Ameye L, Paesmans M, Zielinsky CC, Piccart-Gebhart M, Preusser M (2014) The landscape of medical oncology in Europe by 2020. Ann Oncol 25:525–528CrossRef
6.
7.
8.
Zurück zum Zitat McKenzie H, Hayes L, White K et al (2011) Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study. Support Care Cancer 19:963–969CrossRefPubMed McKenzie H, Hayes L, White K et al (2011) Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study. Support Care Cancer 19:963–969CrossRefPubMed
9.
Zurück zum Zitat Shepperd S, Doll H, Broad J et al (2008) Admission avoidance hospital at home. Cochrane Database Syst Rev 4:CD007491 Shepperd S, Doll H, Broad J et al (2008) Admission avoidance hospital at home. Cochrane Database Syst Rev 4:CD007491
10.
Zurück zum Zitat Shepperd S, Doll H, Broad J et al (2009) Early discharge hospital at home. Cochrane Database Syst Rev 21(1):CD000356 Shepperd S, Doll H, Broad J et al (2009) Early discharge hospital at home. Cochrane Database Syst Rev 21(1):CD000356
12.
Zurück zum Zitat Montalto M, Leff BA (2012) Hospital in the home: a lot’s in a name. Med J Aust 197:479–480CrossRefPubMed Montalto M, Leff BA (2012) Hospital in the home: a lot’s in a name. Med J Aust 197:479–480CrossRefPubMed
13.
Zurück zum Zitat Jones J, Wilson A, Parker H et al (1999) Economic evaluation of hospital at home versus hospital care: cost minimization analysis of data from randomized controlled trial. BMJ 319:1547–1550CrossRefPubMedPubMedCentral Jones J, Wilson A, Parker H et al (1999) Economic evaluation of hospital at home versus hospital care: cost minimization analysis of data from randomized controlled trial. BMJ 319:1547–1550CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Escalante CP, Rubenstein EB, Rolston KV (1996) Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients. Support Care Cancer 4:358–363CrossRefPubMed Escalante CP, Rubenstein EB, Rolston KV (1996) Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients. Support Care Cancer 4:358–363CrossRefPubMed
15.
Zurück zum Zitat Gome B, Callanzani N, Curiale V et al (2013) Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev 6:CD007760 Gome B, Callanzani N, Curiale V et al (2013) Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev 6:CD007760
16.
17.
Zurück zum Zitat Porzio G, Aielli F, Verna L et al (2013) Integrating oncology and palliative home care in Italy: the experience of the “L’Aquila per la Vita” Home Care Unit. Tumori 99:225–228PubMed Porzio G, Aielli F, Verna L et al (2013) Integrating oncology and palliative home care in Italy: the experience of the “L’Aquila per la Vita” Home Care Unit. Tumori 99:225–228PubMed
18.
Zurück zum Zitat Mercadante S, Porzio G, Valle A et al (2012) Emergencies in patients with advanced cancer followed at home. J Pain Symptom Manag 44:295–300CrossRef Mercadante S, Porzio G, Valle A et al (2012) Emergencies in patients with advanced cancer followed at home. J Pain Symptom Manag 44:295–300CrossRef
19.
Zurück zum Zitat Fernández-Avilés F, Carreras E, Urbano-Izpizua A et al (2006) Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematological malignancies. J Clin Oncol 24:4855–4861CrossRefPubMed Fernández-Avilés F, Carreras E, Urbano-Izpizua A et al (2006) Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematological malignancies. J Clin Oncol 24:4855–4861CrossRefPubMed
20.
Zurück zum Zitat Brooks GA, Abrams TA, Meyerhardt JA et al (2014) Identification of potentially avoidable hospitalization in patients with cancer. J Clin Oncol 32:496–503CrossRefPubMedPubMedCentral Brooks GA, Abrams TA, Meyerhardt JA et al (2014) Identification of potentially avoidable hospitalization in patients with cancer. J Clin Oncol 32:496–503CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Nourois J, Novitzky-Basso I, Gill MJ et al (2010) Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 21(Suppl 5):v252–v256CrossRef Nourois J, Novitzky-Basso I, Gill MJ et al (2010) Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 21(Suppl 5):v252–v256CrossRef
22.
Zurück zum Zitat Flowers CR, Seidenfeld J, Bow EJ et al (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(6):794–810CrossRefPubMed Flowers CR, Seidenfeld J, Bow EJ et al (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(6):794–810CrossRefPubMed
23.
Zurück zum Zitat Hannon B, Zimmermann C (2013) Early palliative care: moving from ‘why’ to ‘how’. Oncology 27(1):168738PubMed Hannon B, Zimmermann C (2013) Early palliative care: moving from ‘why’ to ‘how’. Oncology 27(1):168738PubMed
24.
Zurück zum Zitat Nordly M, Benthien KS, Von Der Maase H et al (2014) The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home. BMC Palliat Care 13:44CrossRefPubMedPubMedCentral Nordly M, Benthien KS, Von Der Maase H et al (2014) The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home. BMC Palliat Care 13:44CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat McCorkle R, Dowd M, Ercolano E et al (2009) Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers. Psyconcol 18:62–70CrossRef McCorkle R, Dowd M, Ercolano E et al (2009) Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers. Psyconcol 18:62–70CrossRef
26.
Zurück zum Zitat Thokala P, Baalbaki H, Brennan A et al (2013) Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modeling of alternative service designs. BMJ Open 3:e003250CrossRefPubMedPubMedCentral Thokala P, Baalbaki H, Brennan A et al (2013) Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modeling of alternative service designs. BMJ Open 3:e003250CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Kinnane NA, Milne DJ (2010) The role of the Internet in supporting and informing carers of people with cancer: a literature review. Support Care Cancer 18:1123–1136CrossRefPubMed Kinnane NA, Milne DJ (2010) The role of the Internet in supporting and informing carers of people with cancer: a literature review. Support Care Cancer 18:1123–1136CrossRefPubMed
28.
Zurück zum Zitat Alanee S, Dynda D, LeVault K et al (2014) Delivering kidney cancer care in rural Central and Southern Illinois: a telemedicine approach. J Cancer care (Engl) 23:739–744CrossRef Alanee S, Dynda D, LeVault K et al (2014) Delivering kidney cancer care in rural Central and Southern Illinois: a telemedicine approach. J Cancer care (Engl) 23:739–744CrossRef
29.
Zurück zum Zitat Girault A, Ferrua M, Lalloué B et al (2015) Internet-based technologies to improve cancer care coordination: current use and attitudes among cancer patients. Eur J Cancer 51:551–557CrossRefPubMed Girault A, Ferrua M, Lalloué B et al (2015) Internet-based technologies to improve cancer care coordination: current use and attitudes among cancer patients. Eur J Cancer 51:551–557CrossRefPubMed
30.
Zurück zum Zitat Carmona-Bayonas A, Jimenez-Fonseca P, Virizuela-Echaburu J et al (2015) Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol 33:465–471CrossRefPubMed Carmona-Bayonas A, Jimenez-Fonseca P, Virizuela-Echaburu J et al (2015) Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol 33:465–471CrossRefPubMed
Metadaten
Titel
Home management of acute medical complications in cancer patients: a prospective pilot study
verfasst von
C. Font
F. Fernández-Avilés
C. Calderon
T. García-Fernández
N. Arab
E. Pineda
E. Buxó
P. Ayora
M. Carreño
V. Pereira
M. Viladot
C. Moreno
C. Gallego
A. Hernando
N. Creus
C. Barrera
R. Alcaraz
J. Sanchez
A. Prat
A. Tuca
Publikationsdatum
01.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-3006-0

Weitere Artikel der Ausgabe 5/2016

Supportive Care in Cancer 5/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.